Biogen (BIIB)
NASDAQ:BIIB
BIIBBiogen
$325.40
-$0.96 (-0.29%)

Biogen Stock Forecast & Price Targets

See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
27Ratings
15Buy
12Hold
0Sell
Based on 27 analysts giving stock ratings to
Biogen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

Analyst Price Target on BIIB

Average Price Target

$426.32
▲(31.01% Upside)
Based on 27 Wall Street analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $426.32 with a high forecast of $647.00 and a low forecast of $244.00. The average price target represents a 31.01% change from the last price of $325.40.
Highest Price Target$647.00
Average Price Target$426.32
Lowest Price Target$244.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
William Blair
Buy
Reiterated
Mizuho Securities
$244
Hold
-25.02%
Downside
Assigned
Robert W. Baird
$382
Hold
17.39%
Upside
Assigned
Goldman Sachs
$390
Hold
19.85%
Upside
Reiterated
Bank of America Securities
$400
Hold
22.93%
Upside
Reiterated
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AGLagilon health
SHCSotera Health
TSHATaysha Gene Therapies
CMPSCOMPASS Pathways
IMABI-MAB
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis